1,623,635 American Healthcare REIT, Inc. $AHR Shares Bought by Russell Investments Group Ltd.
Russell Investments Group Ltd. significantly increased its stake in American Healthcare REIT (NYSE:AHR), purchasing over 1.6 million additional shares in the third quarter, bringing its total to 2.4 million shares worth approximately $125.3 million. The REIT reported strong third-quarter earnings, beating analyst estimates with EPS of $0.58 and a 29.5% year-over-year revenue increase. Analysts maintain a positive outlook for AHR, with an average "Buy" rating and a target price of $64.
Zacks Investment Ideas feature highlights: American Healthcare REIT, RenaissanceRe and Cheniere Energy
Amid a potential stall in the AI boom and a sharp correction in the semiconductor sector, Zacks Investment Ideas suggests defensive stock picks outside of technology. The article highlights American Healthcare REIT (AHR), RenaissanceRe (RNR), and Cheniere Energy (LNG) as strong opportunities in healthcare, financials, and oil and gas, respectively. These companies are recommended for their robust fundamentals, favorable earnings revisions, and limited exposure to the tech sector's volatility.
If the AI Boom Stalls, What Stocks Should You Buy?
This article suggests defensive stock picks in healthcare, financials, and oil and gas, as alternatives to the volatile AI and semiconductor sectors, especially if the AI boom falters. It highlights three specific companies: American Healthcare REIT (AHR), RenaissanceRe (RNR), and Cheniere Energy (LNG), detailing their strong fundamentals, favorable earnings revisions, and limited exposure to the AI trade. The author recommends these stocks for diversifying portfolios while maintaining growth potential in a potentially shifting market regime.
American Healthcare REIT (NYSE:AHR) Given New $71.00 Price Target at UBS Group
UBS Group has increased its price target for American Healthcare REIT (NYSE:AHR) to $71.00 from $62.00, reiterating a "buy" rating, which suggests a potential upside of nearly 20%. This positive outlook aligns with the company's recent strong quarterly performance, where it surpassed EPS and revenue estimates. Several other brokerages have also issued "buy" ratings and raised their price objectives for the healthcare REIT.
American Healthcare REIT director Scott Estes sells $148,300 in stock By Investing.com
Scott A. Estes, a director at American Healthcare REIT Inc. (NYSE:AHR), sold 2,500 shares of company stock for $148,300, with shares trading near their 52-week high and delivering a 28% year-to-date return. This sale occurred while InvestingPro analysis suggests the stock is overvalued. The company recently reported strong Q3 results, increased its full-year outlook, and launched a $1.75 billion equity program, leading RBC Capital and Raymond James to raise their price targets.
Citigroup maintains American Healthcare REIT at Buy, raises price target to $67 from $65
Citigroup has reiterated its "Buy" rating for American Healthcare REIT (AHR) and increased its price target to $67 from $65, representing a 3.1% rise. This new price target suggests an upside of 13.6% from the stock's closing price of $58.96 on November 9. Other recent analyst actions have seen price targets ranging from $60 to $66 for AHR.
American Healthcare REIT (NYSE:AHR) Director Scott Estes Sells 2,500 Shares of Stock
American Healthcare REIT (NYSE:AHR) Director Scott Estes sold 2,500 shares of the company's stock for $148,300, reducing his position by 11.63%. Despite the insider sale, the company reported strong quarterly earnings, beating analyst estimates with $0.58 EPS and $742.15 million in revenue. Analysts generally maintain a "Buy" rating for AHR, with a consensus price target of $63.31.
Form 4 American Healthcare REIT Inc: Scott A. Estes (Director) For: 10 November
This article reports a Form 4 filing for American Healthcare REIT Inc, specifically detailing an action by Director Scott A. Estes on November 10. Such filings typically disclose transactions by company insiders in their own company's stock, providing transparency to the market.
Raymond James raises American Healthcare REIT price target on platform strength
Raymond James has raised its price target for American Healthcare REIT (NYSE:AHR) shares from $62 to $72, maintaining a Strong Buy rating, due to the sustained success of Trilogy's operating platform and the company's ability to leverage it across its senior housing assets. The firm increased its estimates by approximately 15% and the price target by over 10%, reflecting confidence in the company's position and accelerating investments expected to boost long-term performance. American Healthcare REIT recently reported strong third-quarter earnings with a 31.8% increase in normalized funds from operations and has initiated an at-the-market equity offering program for up to $1.75 billion in common stock.
American Healthcare REIT stock hits all-time high at 58.71 USD
American Healthcare REIT (AHR) stock has reached an all-time high of $58.69, reflecting significant appreciation and investor confidence in the healthcare real estate sector. Despite appearing overvalued according to InvestingPro, the company recently reported strong Q3 results with normalized funds from operations up 31.8% and revenue of $742.15 million, leading to a raised full-year outlook. Additionally, AHR launched an at-the-market equity offering for up to $1.75 billion of its common stock to strengthen its financial position and expand market presence.
Truist reiterates Buy on American Healthcare REIT stock after earnings
Truist Securities reiterated a Buy rating and a $61.00 price target on American Healthcare REIT (AHR) after its Q3 2026 earnings, citing outperformance driven by higher senior housing operating portfolio revenue growth and lower expenses. The company's stock has shown positive year-to-date returns, and Truist believes AHR is well-positioned to leverage favorable market fundamentals with a low-levered balance sheet. Other firms like KeyBanc, Citizens, and Raymond James have also expressed positive outlooks on AHR's performance and growth prospects.
American Healthcare REIT launches $1.75 billion at-the-market equity program
American Healthcare REIT (NYSE:AHR) has initiated a new $1.75 billion at-the-market (ATM) equity offering program, allowing it to sell common stock through various financial institutions. This move comes as the stock trades near its 52-week high, with shares up nearly 21% year-to-date. The company plans to use the proceeds for general corporate purposes, including future investments, after terminating its previous ATM program.
American Healthcare REIT launches $1.75 billion at-the-market equity program
American Healthcare REIT (NYSE:AHR) has initiated a new at-the-market (ATM) equity offering program, aiming to sell up to $1.75 billion of common stock. This move comes as the stock trades near its 52-week high, with shares up almost 21% year-to-date. The company will use proceeds for general corporate purposes and potential future investments, having terminated a previous ATM program with $170.1 million remaining.
Form 8K American Healthcare REIT Inc For: 6 November By Investing.com
This article reports that American Healthcare REIT Inc. filed a Form 8K on November 6. The content provides basic details about the filing and includes general financial market data and news from Investing.com. It does not elaborate on the specific contents of the 8K filing.
Revenue rises to $742M at American Healthcare REIT (AHR), but quarterly profit falls.
American Healthcare REIT (AHR) reported increased revenue for Q3 2026, reaching $742.1 million compared to $572.9 million in Q3 2025, primarily driven by higher resident fees and services. However, the company's net income attributable to controlling interest fell to $31.2 million from $55.9 million in the prior year, resulting in diluted earnings per share of $0.14 versus $0.33. The decline in profit was largely due to a gain on remeasurement of equity interest and an income tax benefit recorded in the 2025 quarter that were not present in 2026.
American Healthcare REIT Q3 2026 Earnings Call Transcript
American Healthcare REIT reported its Q3 2026 financial results, highlighting its 11th consecutive quarter of double-digit same-store NOI growth at 13.8%. The company raised its full-year guidance, expecting over 30% NFFO per diluted share growth and detailed $2.1 billion in year-to-date investments focused on newer-vintage senior housing in high-barrier markets. Management emphasized strategic growth through operator partnerships and platform enhancements, with a strong balance sheet reflected by a net debt to EBITDA ratio of 1.9 times.
American Healthcare REIT Forecasts 2026 NFFO of $2.23 to $2.26 Per Share
American Healthcare REIT has forecasted its 2026 normalized funds from operations (NFFO) to be between $2.23 and $2.26 per share. The company also raised its full-year same-store net operating income (NOI) growth target to 12%-14% following a strong third-quarter growth of 13.8%, marking its eleventh consecutive quarter of double-digit growth. The increase was attributed to occupancy gains, pricing power, and operational execution.
AHR: American Healthcare REIT Inc. filed SEC Form 8-K: Entry into a...
American Healthcare REIT Inc. (AHR) has filed an SEC Form 8-K announcing a new "at-the-market" equity program to sell up to $1.75 billion of common stock. This program replaces a prior one that had $170.1 million unsold, offering the company flexibility to raise capital but potentially diluting existing shareholders. The proceeds are intended to fund the operating partnership's business.
Are Finance Stocks Lagging American Healthcare REIT, Inc. (AHR) This Year?
American Healthcare REIT (AHR) is currently outperforming the broader Finance sector and its industry peers year-to-date, with a 16.7% return compared to the sector's 3.7%. The company holds a Zacks Rank #2 (Buy), supported by a 5.7% increase in full-year earnings estimates over the last three months. Digital Realty Trust (DLR) is another Finance stock showing strong performance, up 16.5% year-to-date.
American Healthcare REIT Inc (AHR) Cash Flow
This article provides an in-depth analysis of American Healthcare REIT Inc's (AHR) cash flow statements, including operating, investing, and financing activities on both annual and quarterly bases. It details key financial figures such as net income, capital expenditures, and free cash flow, along with year-over-year changes. The piece also includes an FAQ section explaining common cash flow terms and their relevance to AHR.
American Healthcare REIT (AHR) Set to Release Quarterly Earnings on Thursday
American Healthcare REIT (AHR) is scheduled to release its Q3 2026 earnings after market close on Thursday, November 5th, with analysts expecting $0.1539 EPS and $703.51 million in revenue. The company previously exceeded expectations in Q2 2026, reporting $0.16 EPS and $674.25 million in revenue. Analysts generally maintain a "Buy" rating with a $62 price target, despite a high dividend payout ratio.
American Healthcare REIT, Inc. Estimates – BMV:AHR
This article provides financial estimates and data for American Healthcare REIT, Inc. (BMV:AHR) through TradingView. It offers an overview of the company's financials, including income statements, balance sheets, and cash flow, allowing users to compare actual results with analyst estimates. The platform also visualizes trends over time for investment analysis.
American Healthcare REIT, Inc. Estimates – SWB:D6N0
This article provides an overview of American Healthcare REIT, Inc. (SWB:D6N0) on TradingView, detailing its financial data and analyst estimates. Users can explore reported financial data, compare actual results with estimates, and visualize trends over time across income statements, balance sheets, cash flow statements, and valuation metrics. The page emphasizes that the information is not investment advice and encourages users to conduct their own research.
American Healthcare REIT, Inc. (AHR) stock price, news, quote and history
This article provides a comprehensive overview of American Healthcare REIT, Inc. (AHR), including its current stock price, historical performance, and key financial metrics. It details the company's business model as a self-managed REIT focused on clinical healthcare real estate across the U.S., U.K., and the Isle of Man. The report also includes analyst insights, earnings trends, and valuation measures for AHR.
How Higher Earnings Estimates Will Impact American Healthcare REIT Stock
American Healthcare REIT, Inc. is anticipated to report increased EPS and revenue on November 5th, with recent analyst estimate revisions suggesting stronger operating performance. The article explores how these higher expectations could influence the REIT's investment profile and risk, particularly concerning its senior housing, skilled nursing, and outpatient medical assets. While the earnings report will offer a check-in on the company's portfolio optimization strategy, key risks like reimbursement exposure and integration of value-add properties are unlikely to change materially.
How Higher Earnings Estimates Will Impact American Healthcare REIT Stock
American Healthcare REIT is expected to report higher EPS and revenue for its upcoming quarterly earnings on November 5, reflecting increased confidence in its operating performance. The upward revision of EPS estimates by 3.5% signals rising expectations, particularly regarding the stabilization of its Trilogy and SHOP segments and the integration of value-add properties. This earnings report will serve as a crucial check on the REIT's strategy for portfolio optimization and acquisition of non-stabilized assets, with analysts projecting significant growth in earnings and revenue by 2029.
American Healthcare REIT, Inc. Estimates – BOATS:AHR
This article provides access to the financial estimates for American Healthcare REIT, Inc. (AHR), including data from its income statement, balance sheet, and cash flow statement, along with valuation metrics. It allows users to compare actual results with analyst estimates (average, high, low) and visualize trends over time. The information is presented by TradingView, sourcing data from ICE Data Services, FactSet, and Quartr.
American Healthcare REIT, Inc. Estimates – LSX:A3E3SP
This article provides an overview of American Healthcare REIT, Inc. (A3E3SP) on the Lang & Schwarz Exchange, focusing on its financial data and analyst estimates. It highlights access to reported financial data, income statements, balance sheets, cash flow statements, and valuation metrics for comparison with average, high, and low estimates. The content emphasizes that the information is not investment advice and encourages users to conduct their own research.
Is American Healthcare REIT, Inc. (AHR) Stock Outpacing Its Finance Peers This Year?
American Healthcare REIT (AHR) has shown strong year-to-date performance, returning 13.1% and outpacing the Finance sector's average of 3.2%. The company holds a Zacks Rank of #2 (Buy), reflecting positive analyst sentiment and an improving earnings outlook. Another Finance stock, HCI Group (HCI), has also outperformed the sector with a 3.6% return year-to-date.
TD Waterhouse Canada Inc. Acquires 59,425 Shares of American Healthcare REIT, Inc. $AHR
TD Waterhouse Canada Inc. has increased its stake in American Healthcare REIT, Inc. (NYSE:AHR) by 25.6%, purchasing an additional 59,425 shares to own a total of 291,978 shares valued at approximately $14.8 million. This acquisition is part of a broader trend of institutional investment in AHR, which has seen positive analyst ratings with a consensus "Buy" and a target price of $62.00, alongside strong financial performance in its latest quarterly report. The company also announced a quarterly dividend of $0.25, reflecting an annualized yield of 1.9%.
AMERICAN HEALTHCARE REIT, INC. : RAYMOND JAMES INITIATES COVERAGE WITH STRONG BUY RATING; TARGET PRICE $62
Raymond James has initiated coverage on American Healthcare REIT, Inc. with a "Strong Buy" rating. The firm has set a target price of $62 for the company's stock. This news indicates a positive outlook from Raymond James on the healthcare REIT's future performance.
American Healthcare REIT (AHR) Gets Raymond James Backing, Is It Still A Bargain?
Raymond James initiated coverage on American Healthcare REIT (AHR) with a favorable view, highlighting its diversified healthcare portfolio. The stock has shown recent momentum with a 4.04% 7-day return and 11.20% year-to-date return. Despite appearing 18% undervalued based on a discounted cash flow model, its P/E ratio of 100.4x is significantly higher than the industry average, suggesting potential valuation risk.
American Healthcare REIT Price Target Cut to $62.00/Share From $63.00 by UBS
UBS has adjusted its price target for American Healthcare REIT, lowering it to $62.00 per share from the previous $63.00. This revision indicates a slight downgrade in the analyst's valuation of the company's stock. Investors may want to note this change in analyst sentiment.
Raymond James Initiates American Healthcare REIT(AHR.US) With Buy Rating, Announces Target Price $62
Raymond James has initiated coverage on American Healthcare REIT (AHR.US) with a "Buy" rating. The firm has also set a target price of $62 for the company's stock. This initiation suggests a positive outlook from Raymond James regarding American Healthcare REIT's future performance.
Raymond James initiates American Healthcare REIT stock at strong buy on Trilogy partnership By Investing.com
Raymond James has initiated coverage on American Healthcare REIT (AHR) with a "Strong Buy" rating and a $62.00 price target, citing its strong operating relationship with Trilogy as a key differentiator. The firm highlighted AHR's robust balance sheet, selective investments, and expected near-term organic growth, further enhanced by acquisitions and development. InvestingPro analysis suggests AHR is overvalued despite its "GREAT" financial health, while other analysts like KeyBanc and Citizens also maintain positive outlooks with raised price targets following strong Q2 2026 results.
American Healthcare REIT (NYSE:AHR) Stock Gets Price Target Reduction from UBS Group
UBS Group has reduced its price target for American Healthcare REIT (NYSE:AHR) from $63 to $62, while maintaining a "buy" rating, indicating an 18.12% potential upside. The company surpassed quarterly earnings expectations, reporting $0.16 EPS against an expected $0.14 and revenue of $674.25 million, a 24.3% year-over-year increase. Analyst sentiment remains largely positive, with an average "Buy" rating and a consensus target price of $62.
Raymond James initiates American Healthcare REIT stock at strong buy on Trilogy partnership
Raymond James has initiated coverage on American Healthcare REIT (NYSE:AHR) with a Strong Buy rating and a $62.00 price target, citing the company's strong operating relationship with Trilogy. The firm highlighted American Healthcare REIT's ability to drive performance in its seniors assets, maintain a supportive cost of capital, and its strong balance sheet. The company also recently reported strong Q2 2026 results, surpassing FFO and revenue estimates, and has a significant acquisition pipeline.
American Healthcare REIT Inc (AHR) Stock Up 3.4% but GF Value Says Overvalued -- GF Score: 59/100
American Healthcare REIT Inc (AHR) shares rose 3.4% to $52.52, but GuruFocus's GF Value™ indicates the stock is significantly overvalued at a 65.1% premium to its intrinsic value of $31.81. The company has an average GF Score™ of 59/100, with strong growth but poor valuation and momentum rankings. Insider activity shows significant selling with no buying, suggesting caution for potential investors.
American Healthcare REIT, Inc. (NYSE:AHR) Stock Has Average Target Price of $62.75 According to Brokerages
American Healthcare REIT, Inc. (NYSE:AHR) has received an average "Buy" rating from fourteen brokerages, with an average one-year target price of $62.75, significantly higher than its opening price of $50.77. The company recently reported strong quarterly earnings, beating analyst estimates for both EPS and revenue, and declared a quarterly dividend of $0.25 per share. Several analysts have updated their ratings and price targets, indicating continued bullish sentiment for AHR stock.
(AHR) and the Role of Price-Sensitive Allocations
This article provides an AI-driven analysis for American Healthcare Reit Inc. (NYSE: AHR), highlighting weak near and mid-term sentiment but a strong long-term outlook. It details specific institutional trading strategies, including long, breakout, and short positions with defined entry points, targets, and stop losses. The analysis also includes a multi-timeframe signal breakdown for support and resistance levels.
Are Finance Stocks Lagging American Healthcare REIT, Inc. (AHR) This Year?
American Healthcare REIT (AHR) has outperformed the Finance sector and its specific industry year-to-date, with a 7.7% return compared to the sector's 2.2% gain. The company holds a Zacks Rank of #2 (Buy) due to improving analyst sentiment and a positive earnings outlook. Another strong performer mentioned is Banco Bilbao (BBVA), which is up 15.3% this year.
BMO Capital Maintains American Healthcare REIT(AHR.US) With Buy Rating, Raises Target Price to $65
BMO Capital has reiterated its Buy rating for American Healthcare REIT (AHR.US) and increased the target price to $65. This adjustment suggests a positive outlook on the company's stock performance from the analytical firm.
Form 4 American Healthcare REIT Inc For: 28 September By Investing.com
This article reports on a Form 4 filing for American Healthcare REIT Inc. on September 28. It provides the title of the filing and mentions that more financial news and data are available on Investing.com. The content also includes various market data like indices, commodities, and stock performances.
American healthcare REIT EVP Mark Foster sells $78,090 in stock By Investing.com
Mark E. Foster, EVP of American Healthcare REIT (AHR), recently sold 1,500 shares of company stock for $78,090. This transaction leaves him with 50,117 shares. The sale follows a 26% return for AHR shares over the past year, although InvestingPro analysis suggests the stock is currently overvalued.
Form 4 American Healthcare REIT Inc For: 28 September By Investing.com
This article reports on the filing of Form 4 by American Healthcare REIT Inc. on September 28, 2026. Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) by company insiders to report transactions in their company's stock. The article itself is brief, primarily serving as an announcement of the filing rather than providing detailed analysis of its contents.
American healthcare REIT EVP Mark Foster sells $78,090 in stock
Mark E. Foster, EVP, General Counsel, and Secretary of American Healthcare REIT (AHR), recently sold 1,500 shares of company stock for $78,090. This transaction leaves him with 50,117 shares. The sale follows a 26% return for AHR shares over the past year, although InvestingPro analysis suggests the stock is currently overvalued.
American Healthcare REIT (AHR) 10K Form and Latest SEC Filings 2026
This article provides access to American Healthcare REIT's (AHR) latest SEC filings and historical data. It highlights the importance of these filings for investors, detailing various form types like 10-K, 10-Q, and 8-K, and their significance for understanding a company's financial health and business events. The most recent filing mentioned is a Form 4 submitted on September 28, 2026, indicating an ownership change.
Zacks Industry Outlook Highlights American Healthcare REIT, Terreno Realty and RLJ Lodging Trust
The article discusses the challenges faced by the Equity REIT industry, such as higher interest rates and construction costs, but notes that demand for modern assets in healthcare, industrial, lodging, office, and infrastructure remains strong. It highlights American Healthcare REIT (AHR), Terreno Realty Corporation (TRNO), and RLJ Lodging Trust (RLJ) as three companies well-positioned for growth despite industry headwinds, attributing their potential to diversified portfolios, strategic acquisitions, and strong balance sheets. These REITs are recommended as "Buy" stocks by Zacks, with positive FFO per share revisions.
3 Equity REIT Stocks Worth Betting on Despite Industry Headwinds
Despite headwinds from high interest rates, bond yields, and construction costs, the Equity REIT industry shows promise in certain segments. Modern assets in healthcare, industrial, lodging, office, and infrastructure markets are experiencing healthy demand. This article highlights three REITs—American Healthcare REIT (AHR), Terreno Realty Corporation (TRNO), and RLJ Lodging Trust (RLJ)—as strong investment opportunities due to their well-positioned properties, disciplined management, and growth potential.
American Healthcare REIT, Inc. Common Stock (NYSE:AHR) Detailed Stock Data
This article provides detailed stock data for American Healthcare REIT, Inc. (NYSE: AHR). It includes current trading information, price performance metrics, and key financial ratios. The data shows a recent closing price of $51.69, a slight decrease for the day, and highlights the company's year-to-date and annual price performance.